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Methods 
Perspex chambers containing Matrigel, bFGF 
(1000 ng/ml, Sigma, Denmark) and VEGF (500 
ng/ml, Sigma, Denmark) were assembled as 
previously described3 (figure 1). Following ra-
diation sterilization, the chambers were im-
planted subcutaneously on both flanks of 24 
male NMRI nu/nu mice. Magnetic resonance 
imaging was performed using a 4.7T Varian sys-
tem two weeks after implantation under hyp-
norm/dormicum anesthesia. Contrast agent was 
administered via a cannulated tail vein (0.4mg 
Endorem, n=12, 0.3ml Magnevist, n=12). 
Following MR examination, the chambers were 
excised and imaged using a digital camera. 
 
Results & Discussion 
Figure 2 shows significant enhancement of the 
Matrigel chamber following administration of 
GdDTPA. The region of cellular infiltration ap-
parent in figure 2 (left) becomes hyperintense 
compared to uninfiltrated Matrigel (right). The 
high vascular permeability due to VEGF results 
in diffuse contrast enhancement. The long T2 
values of the Matrigel chamber prior to implan-
tation suggested the use of a T2* blood pool 
agent (Endorem), to provide more vascular spe-
cific information. As shown in figure 3 (left), a 
region of cellular infiltration is seen in the up-
per left region of the image. What appears to 
be a vessel may be seen on the dMRI differ-
ence map (red ROI, middle). Some correspon-
dence between the post contrast T2 map (left) 
and dMRI difference (middle) is seen. As shown 
in the time curves (right), three distinct regions 
could be identified. The red region appears to 
be a vessel where washout causes the signal to 
Introduction 
Angiogenesis is a critical process in tumour de-
velopment and presents an important target for 
the development of a range of anti-cancer 
agents1,2. To assess the in vivo efficacy of these 
‘an gioth erap eu tics’, a sim p le an d  rep rod u cib le 
in vivo model would be of significant value. 
Here we show that a gel containing pro-
angiogenic agents held within a chamber may 
be positioned sub-cutaneously in mice and the 
angiogenic process followed using MR 
methods. This approach allows an individual 
animal to be followed with time in order to stu-
dy the initial development of vasculature within 
the chambers. 
increase slightly following initial signal reduc-
tion following contrast agent administration. 
The green and blue regions are different parts 
of the infiltration that might have different 
vascular or cell densities. 
The dMRI difference maps show the initial ef-
fects of the contrast agent while the T2 maps 
show the extent of tissue infiltration and 
steady state effects. The difference between 
Figure 3 left and middle may be interpreted 
as an area corresponding to a vessel (red ROI) 
where the intravascular contrast agent clears 
before the post contrast T2 map is acquired. 
Conclusion 
This study has shown that it is possible to moni-
tor angiogenesis using a minimally invasive mag-
netic resonance method in vivo. Furthermore, a 
single animal may be followed longitudinally 
and act as its own control. The method may be 
developed further to study the effects of agents 
designed to influence the angiogenic process. 
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Figure 1: Schematic diagram of the assembly and imaging of the chamber 
Figure 2: Ex vivo optical ima-
ge (left) together with in vivo 
pre- (middle) and post- 
(right) contrast (Magnevist, 
0.3 ml) T1W spin echo ima-
ges (TR/TE 300/3 ms) of the 
same Matrigel implant.  
Figure 3: Left: Quantitative T2 image post contrast (multiple readout spin echo se-
quence, TR=3s, TE=15-180ms in steps of 15ms, T2 values obtained by least squares 
fitting). Middle: dMRI difference image (gradient echo FLASH sequence, TR/TE=20/5.2 
m s, Fl=  2 0 °, nt= 1 5 0 ). The im age show n is the d ifference b etw een the m ean of the 25 
first and last images. Right: Time curves for the ROIs shown in the dMRI difference 
map (middle) are shown in the plot. 
Whilst a previous study by Pilatus, U. et al.4  has 
shown the potential of using Matrigel for study-
ing cell invasion, this study has applied MRI 
methods to study vascular development in an in 
vivo model. 
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